Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: A systematic review

Transfusion Medicine Reviews

Volumn 27, Issue 2, 2013, Pages 91-104

  Lin, David M ^a   Murphy, Linda S ^b   Tran, Minh Ha ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN CONCENTRATE; PROTHROMBIN COMPLEX; VITAMIN K GROUP; WARFARIN;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CINAHL; COCHRANE LIBRARY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HEART SURGERY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MEDLINE; METHODOLOGY; PERIOPERATIVE PERIOD; PLASMA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SURGICAL PATIENT; SYSTEMATIC REVIEW;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CARDIAC SURGICAL PROCEDURES; FIBRINOGEN; HEMOSTATICS; HUMANS; META-ANALYSIS AS TOPIC; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; TREATMENT OUTCOME; WARFARIN;

EID: 84876142253     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2013.01.002     Document Type: Review

References (34)

1. Carson J.L., Grossman B.J., Kleinman S., Tinmouth A.T., Marques M.B., Fung M.K., et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012, 157:49-58.
2. Stanworth S.J., Brunskill S.J., Hyde C.J., McClelland D.B., Murphy M.F. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004, 126:139-152.
3. Yang L., Stanworth S., Hopewell S., Doree C., Murphy M. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012, 52:1673-1686.
4. Abdel-Wahab O.I., Healy B., Dzik W.H. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006, 46:1279-1285.
5. Holland L.L., Brooks J.P. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006, 126:133-139.
6. Yazer M.H. The how's and why's of evidence based plasma therapy. Korean J Hematol 2010, 45:152-157.
7. Benjamin R.J., McLaughlin L.S. Plasma components: properties, differences, and uses. Transfusion 2012, 52:9S-19S.
8. Pandey S., Vyas G.N. Adverse effects of plasma transfusion. Transfusion 2012, 52:65S-79S.
9. Callum J.L., Karkouti K., Lin Y. Cryoprecipitate: the current state of knowledge. Transfus Med Rev 2009, 23:177-188.
10. Karlsson M., Ternstrom L., Hyllner M., Baghaei F., Flinck A., Skrtic S., et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009, 102:137-144.
11. Lance M.D., Ninivaggi M., Schols S.E.M., Feijge M.A., Oehrl S.K., Kuiper G.J., et al. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial. Vox Sang 2012, 103:25-34.
12. Demeyere R., Gillardin S., Arnout J., Strengers P.F.W. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox Sang 2010, 99:251-260.
13. Rahe-Meyer N., Pichlmaier M., Haverich A., Solomon C., Winterhalter M., Piepenbrock S., et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009, 102:785-792.
14. Rahe-Meyer N., Solomon C., Winterhalter M., Piepenbrock S., Tanaka K., Haverich A., et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009, 138:694-702.
15. Solomon C., Schochl H., Hanke A., Calatzis A., Hagl C., Tanaka K., et al. Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. Scand J Clin Lab Invest 2012, 72:121-128.
16. Arnekian V., Camous J., Fattal S., Rezaiguia-Delclaux S., Nottin R., Stephan F. Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 2012, 15:382-389.
17. Gorlinger K., Dirkmann D., Hanke A.A., Kamler M., Kottenberg E., Thielmann M., et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011, 115:1179-1191.
18. Fenger-Eriksen C., Jensen T.M., Kristensen B.S., Jensen K.M., Tonnesen E., Ingerslev J., et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cytectomy: a randomized, placebo controlled clinical trial. J Thromb Haemost 2009, 7:795-802.
19. Nienaber U., Innerhofer P., Westermann I., Schochl H., Attal R., Breitkopf R., et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011, 42:697-701.
20. Schochl H., Nienaber U., Maegele M., Hochleitner G., Primavesi F., Steitz B., et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011, 15:R83.
21. Theodoulou A., Berryman J., Nathwani A., Scully M. Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenemia. Transfus Apher Sci 2012, 46:159-162.
22. Boulis N.M., Bobek M.P., Schmaier A., Hoff J.T. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999, 45:1113-1118.
23. Cartmill M., Dolan G., Byrne J.L., Byrne P.O. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000, 14:458-461.
24. Kalina M., Tinkoff G., Gbadebo A., Veneri P., Fulda G. A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy. Am Surg 2008, 74:858-861.
25. Holland L., Warkentin T.E., Refaai M., Crowther M.A., Johnston M.A., Sarode R. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009, 49:1171-1177.
26. Huttner H.B., Schellinger P.D., Hartmann M., Kohrmann M., Juettler E., Wikner J., et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006, 37:1465-1470.
27. Kuwashiro T., Yasaka M., Itabashi R., Nakagaki H., Miyashita F., Naritomi H., et al. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage. Cerebrovasc Dis 2011, 31:170-176.
28. Pinner N.A., Hurdle A.C., Oliphant C., Reaves A., Lobo B., Sills A. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII. World Neurosurg 2010, 74:631-635.
29. Chapman S.A., Irwin E.D., Beal A.L., Kulinski N.M., Hutson K.E., Thorson M.A. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin. Ann Pharmacother 2011, 45:869-875.
30. Fenger-Eriksen C., Moore G.W., Rangarajan S., Ingerslev J., Sorensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010, 50:2571-2576.
31. Urwyler N., Theiler L., Hirschberg M., Kleine-Brueggeney M., Colucci G., Greif R. Standard vs. point-of-care measurement of fibrinogen: potential impact on clinical decisions. Minerva Anestesiol 2012, 78:550-555.
32. Lubetsky A., Yonath H., Olchovsky D., Loebstein R., Halkin H., Ezra D. Comparison of oral vs intravenous Phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective, randomized controlled trial. Arch Int Med 2004, 163:2469-2473.
33. Hambleton J., Wages D., Radu-Radulescu L., Adams M., MacKenzie M., Shafer S., et al. Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticougulated with warfarin. Transfusion 2002, 42:1302-1307.
34. Patriquin C., Crowther M. Treatment of warfarin-associated coagulopathy with vitamin K. Exp Rev Hematol 2011, 4:657-667.